2017 Infectious Disease Testing Technologies and Market Applications

January 2017 | 61 pages | ID: ICB3524FBECEN
Venture Planning Group

Abstracts

This report provides a detailed analysis of the current and emerging technologies, and their potential applications for the infectious disease testing market, including DNA probes, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scattering, chromatography and several others.

Contains 61 pages

Contents

1. MOLECULAR DIAGNOSTICS
    a. Technology Overview
    b. Amplification Methods
  POLYMERASE CHAIN REACTION
Temperature Cyclers
PCR Variations
  IMMUNOPCR
  QCPCR
  DAPPCR
  LIGASE CHAIN REACTION
  BRANCHED DNA
  QBETA REPLICASE
  NUCLEICACID SEQUENCEBASED
  STRAND DISPLACEMENT ACTIVATION
  2. MONOCLONAL ANTIBODIES
  3. IMMUNOASSAYS
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
  OVERVIEW
  ELISA
  DOT IMMUNOBINDING ASSAYS
  CAPILLARY IMMUNOASSAYS
  PARTICLEMEMBRANE CAPTURE IMMUNOASSAYS
  ENZYME AMPLIFICATION
    c. Fluorescent Immunoassays
  FLUORESCENCE POLARIZATION
  TIMERESOLVED PULSE FLUORESCENCE
    d. Luminescence
  CHEMILUMINESCENCE
  BIOLUMINESCENCE
    e. Latex Agglutination
    f. Immunoprecipitation
  4. DIFFERENTIAL LIGHT SCATTERING
  5. IT
  6. ARTIFICIAL INTELLIGENCE
  7. LIPOSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. MRI
  11. GEL MICRODROPLETS
  12. OTHER